POTASSIUM ACETATE INJECTION USP
JUNO PHARMA CANADA INC.
Quick answers
Is there a shortage of POTASSIUM ACETATE INJECTION USP in Canada?
No. There is no current shortage of POTASSIUM ACETATE INJECTION USP 39.2% reported to Health Canada. Stock can still vary from one pharmacy to another.
⚠ Possible Recall or Safety Alert
Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.
Sodium Acetate Injection USP
Sodium Acetate Injection USP; Incorrect GTIN
Moderate health risk
Possible match — not confirmed
Sodium Acetate Injection, USP
Sodium Acetate Injection, USP - Potential for the Presence of Particulate Matter
Possible match — not confirmed
Sodium Acetate Injection, USP
Sodium Acetate Injection, USP: Particulate matter
Highest health risk
Possible match — not confirmed
DIN
02362597
Strength
39.2%
Dosage Form
Solution
Route
Intravenous
Compare with another product →
Product Monograph
Product monograph is not available from Health Canada
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from JUNO PHARMA CANADA INC.
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
100MG · DIN 02561557
0.01% · DIN 02529580
100MG · DIN 00821780
100MCG · DIN 02489244
250MCG · DIN 02538377
50MG · DIN 02460947
70MG · DIN 02460955
2MG · DIN 02408813
100MCG · DIN 02467976
400MCG · DIN 02487373
200MCG · DIN 02487365
250MG · DIN 02544083